Next-Generation Weight-Loss Drugs Aim To Outperform Zepbound (LLY) And Wegovy (NVO) On Side Effects And Results
A new wave of experimental weight-loss drugs is drawing serious attention from researchers and patients frustrated with the limitations of current GLP-1 medications. Drugs like Zepbound and Wegovy have transformed obesity treatment, but persistent side effects such as severe nausea and vomiting remain a significant barrier for many patients. Scientists are now developing alternatives that…